SELF-TEST INSTRUMENT FOR GLYCATED HEMOGLOBIN - ANVISA Registration 80117580759

Access comprehensive regulatory information for SELF-TEST INSTRUMENT FOR GLYCATED HEMOGLOBIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80117580759 and manufactured by APEX BIOTECHNOLOGY CORPORATION. The registration is held by EMERGO BRAZIL IMPORT IMPORTACAO E DISTRIBUICAO DE PRODUTOS MEDICOS HOSPITALARES LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including Eco Diagnostica Ltda, POLYMER TECHNOLOGY SYSTEMS, INC., and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.